Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IUB ADIRA
- Development stage
- Preclinical
- Lead developer
- OCON Therapeutics
- Modality
- Small Molecules
- Administration
- Intrauterine
01
Overview
IUB ADIRA is an intrauterine drug delivery system developed by OCON Therapeutics for the treatment of uterine fibroids. It is based on the company's proprietary IUB (Intra-Uterine Ball) platform, which features a flexible, spherical frame made of nitinol (a shape-memory alloy). This spherical design is intended to improve patient comfort and reduce the risks of malposition or uterine perforation associated with traditional T-shaped intrauterine devices. The IUB ADIRA system is designed to provide sustained, local delivery of therapeutic agents directly to the uterine cavity to manage fibroid symptoms and growth.
- Brand names
- IUB ADIRA
Beyond the preview
Go deeper on IUB ADIRA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IUB ADIRA.